Atrial fibrillation
Researchers from the Department of Internal Medicine have conducted a comprehensive analysis of mortality trends due to hypertension-attributable factors and atrial fibrillation in the United States from 1999 to 2020. The study highlights the alarming rise in age-adjusted mortality rates (AAMR) and crude mortality rates (CMR) across various demographic groups,
Atrial fibrillation
Researchers from the Department of Internal Medicine have conducted a comprehensive analysis of mortality trends due to hypertension-attributable factors and atrial fibrillation in the United States from 1999 to 2020. The study highlights the alarming rise in age-adjusted mortality rates (AAMR) and crude mortality rates (CMR) across various demographic groups,
Atrial fibrillation
Researchers from the Department of Internal Medicine have conducted a comprehensive analysis of mortality trends due to hypertension-attributable factors and atrial fibrillation in the United States from 1999 to 2020. The study highlights the alarming rise in age-adjusted mortality rates (AAMR) and crude mortality rates (CMR) across various demographic groups,
Associations
The American Heart Association has announced a new effort to increase clinical trial participation and speed diagnosis of aortic stenosis (AS), a common but underdiagnosed heart valve condition, among people living with moderate AS. Aortic stenosis is characterized by the narrowing of the aortic valve opening, which restricts blood flow
Coronary heart disease
Researchers from Nanjing Medical University have developed a dual-signal surface-enhanced Raman scattering (SERS) platform, dubbed Gemini, to detect early warning signs of heart disease. The platform integrates antibody-functionalized gold nanoparticles for protein recognition and a boronate-based SERS nanotag responsive to hydrogen peroxide generated from a pyruvate oxidase-mediated cascade. This innovative
Defibrillators
Researchers at Medizinische Hochschule Hannover have made significant progress in preventing sudden cardiac death through the development of the extravascular implantable cardioverter-defibrillator (EV-ICD). This innovative device offers a fully extravascular alternative to traditional transvenous ICDs, reducing the risk of intravascular complications while maintaining comparable generator size and longevity. The EV-ICD
Fibrillation
Researchers at Scripps Memorial Hospital have made significant breakthroughs in the development of leadless pacemakers and extravascular implantable cardioverter-defibrillators (ICDs). These innovations offer promising alternatives for patients requiring both defibrillation and pacing, particularly those unable or unwilling to accommodate traditional leads. However, the interactions between extravascular ICDs and leadless pacemakers
Atrial fibrillation
Research has unveiled new data on Heart Disorders and Diseases - Atrial Fibrillation, specifically focusing on the long-term outcomes post-ablation in patients with tachy-brady syndrome (TBS). A study published in the Journal of Cardiovascular Electrophysiology found that among 3,440 patients who underwent atrial fibrillation (AF) ablation, 111 (3.2%
Heart
A novel research study has made significant breakthroughs in heart disease diagnosis and management by proposing a multi-tiered data acquisition model that utilizes deep learning methods. The study, conducted by researchers at Maharshi Dayanand University, aimed to develop an accurate diagnosis system for heart disease using a data-driven forecasting framework.
Heart
A novel research study has made significant breakthroughs in heart disease diagnosis and management by proposing a multi-tiered data acquisition model that utilizes deep learning methods. The study, conducted by researchers at Maharshi Dayanand University, aimed to develop an accurate diagnosis system for heart disease using a data-driven forecasting framework.
Adipose tissue
Researchers at Huazhong University of Science and Technology have conducted a study on left ventricular diastolic dysfunction (LVDD), a condition associated with diminished quality of life and high mortality. According to the study, LVDD can progress to heart failure, and timely diagnosis and effective treatment rely on a thorough understanding
Artificial intelligence
Recent research from Wroclaw, Poland, has identified the potential of artificial intelligence (AI) in detecting patients with subclinical cardiac dysfunction and predicting incident heart failure risk. The study, published in ESC Heart Failure, highlights the significance of AI in facilitating non-expert acquisition and interpretation of echocardiography, thereby enhancing the value
